Omega Therapeutics Deal History & Licensing Activity
Omega Therapeutics is a life sciences. Over the past three years, Omega Therapeutics has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (1 deal).
Deals (12mo)
0
Active Trials
0
Top Modality
Other
Focus Area
Metabolic
Omega Therapeutics Pipeline Focus
Therapeutic areas and modalities where Omega Therapeutics is most active based on deal history and clinical trial data.
Omega Therapeutics Strategic Signals
Key indicators of Omega Therapeutics's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Omega Therapeutics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Metabolic assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Metabolic Deal Benchmarks
Market sizing, deal terms, and competitive landscape for metabolic
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Omega Therapeutics Licensing & Deal Activity
Omega Therapeutics is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Omega Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Omega Therapeutics include Metabolic (1 deal and trial). In terms of modality, Omega Therapeutics has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Omega Therapeutics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Omega Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.